These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8568796)

  • 1. Discovery of the hemifumarate and (alpha-L-alanyloxy)methyl ether as prodrugs of an antirheumatic oxindole: prodrugs for the enolic OH group.
    Robinson RP; Reiter LA; Barth WE; Campeta AM; Cooper K; Cronin BJ; Destito R; Donahue KM; Falkner FC; Fiese EF; Johnson DL; Kuperman AV; Liston TE; Malloy D; Martin JJ; Mitchell DY; Rusek FW; Shamblin SL; Wright CF
    J Med Chem; 1996 Jan; 39(1):10-8. PubMed ID: 8568796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group.
    Robinson RP; Reiter LA; Barth WE; Campeta AM; Cooper K; Cronin BJ; Destito R; Donahue KM; Falkner FC; Fiese EF; Johnson DL; Kuperman AV; Liston TE; Malloy D; Martin JJ; Mitchell DY; Rusek FW; Shamblin SL; Wright CF
    J Med Chem; 2018 Apr; 61(7):3237. PubMed ID: 29589934
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological activity and hydrolysis behavior of novel ibuprofen glucopyranoside conjugates.
    Zhao X; Tao X; Wei D; Song Q
    Eur J Med Chem; 2006 Nov; 41(11):1352-8. PubMed ID: 16806590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
    Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J
    J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorzoxazone esters of some non-steroidal anti-inflammatory (NSAI) carboxylic acids as mutual prodrugs: design, synthesis, pharmacological investigations and docking studies.
    Abdel-Azeem AZ; Abdel-Hafez AA; El-Karamany GS; Farag HH
    Bioorg Med Chem; 2009 May; 17(10):3665-70. PubMed ID: 19398345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs].
    Fu XZ; Wang YL; Lan YY; Wang AM; Ou Y; Luo C; Li Y
    Yao Xue Xue Bao; 2010 Aug; 45(8):1017-24. PubMed ID: 21351588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs.
    Bandarage UK; Chen L; Fang X; Garvey DS; Glavin A; Janero DR; Letts LG; Mercer GJ; Saha JK; Schroeder JD; Shumway MJ; Tam SW
    J Med Chem; 2000 Oct; 43(21):4005-16. PubMed ID: 11052806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of prodrugs for anti-angiogenic pyrrolylmethylidenyl oxindoles.
    Maskell L; Blanche EA; Colucci MA; Whatmore JL; Moody CJ
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1575-8. PubMed ID: 17254788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
    Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
    Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-targeting glycol and NSAIDS ester prodrugs of rhein: synthesis, hydroxyapatite affinity, stability, anti-inflammatory, ulcerogenicity index and pharmacokinetics studies.
    Cai J; Duan Y; Yu J; Chen J; Chao M; Ji M
    Eur J Med Chem; 2012 Sep; 55():409-19. PubMed ID: 22901311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid.
    Khan MS; Akhter M
    Pharmazie; 2005 Feb; 60(2):110-4. PubMed ID: 15739898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and metabolic study of naproxen-propyphenazone mutual prodrug.
    Sheha M; Khedr A; Elsherief H
    Eur J Pharm Sci; 2002 Nov; 17(3):121-30. PubMed ID: 12393139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations.
    Curcio A; Sasso O; Melisi D; Nieddu M; La Rana G; Russo R; Gavini E; Boatto G; Abignente E; Calignano A; Rimoli MG
    J Med Chem; 2009 Jun; 52(12):3794-800. PubMed ID: 19459639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor.
    Liu C; Lin J; Hynes J; Wu H; Wrobleski ST; Lin S; Dhar TG; Vrudhula VM; Sun JH; Chao S; Zhao R; Wang B; Chen BC; Everlof G; Gesenberg C; Zhang H; Marathe PH; McIntyre KW; Taylor TL; Gillooly K; Shuster DJ; McKinnon M; Dodd JH; Barrish JC; Schieven GL; Leftheris K
    J Med Chem; 2015 Oct; 58(19):7775-84. PubMed ID: 26359680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological studies of different duocarmycin based glycosidic prodrugs for their use in the antibody-directed enzyme prodrug therapy.
    Tietze LF; Schuster HJ; Krewer B; Schuberth I
    J Med Chem; 2009 Jan; 52(2):537-43. PubMed ID: 19143570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-Sensitive metal-free carbon monoxide prodrugs with tunable and predictable release rates.
    Ji X; De La Cruz LKC; Pan Z; Chittavong V; Wang B
    Chem Commun (Camb); 2017 Aug; 53(69):9628-9631. PubMed ID: 28809970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and stability of two indomethacin prodrugs.
    Chandrasekaran S; Al-Ghananeem AM; Riggs RM; Crooks PA
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1874-9. PubMed ID: 16439128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Pharmacological Evaluation of Acrylate-Based Gastrosparing NSAID Prodrugs.
    Rasheed A; Yalavarthi PR; Cheramparambil H; Peesa JP; Abdul Khareem A
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28244144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, stability studies, anti-inflammatory activity and ulcerogenicity of morpholinoalkyl ester prodrugs of niflumic acid.
    Talath S; Gadad AK
    Arzneimittelforschung; 2006; 56(11):744-52. PubMed ID: 17220052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.